Navigation Links
3SBio Inc. Announces Second Quarter 2008 Results
Date:8/12/2008

2007, while revenue from our in-licensed Iron Sucrose supplement was RMB2.1 million (US$0.3 million), representing an increase of 255.9% over the second quarter 2007.

Gross Profit. Gross profit increased 38.9% to RMB54.3 million (US$7.9 million) for the second quarter 2008 from RMB39.1 million in the second quarter 2007. Gross margin was 91.1% in the second quarter 2008, marginally increasing from 90.8% in the second quarter 2007.

Operating Expenses. Total operating expenses increased by 54.3% to RMB39.1 (US$5.7 million) in the second quarter 2008 from RMB25.3 million in the second quarter of 2007 primarily due to increases in sales, marketing and distribution expense and general and administrative expense, and to a lesser extent due to an increase in research and development expense.

Research and development expense, representing 5.1% of total net revenues, increased by 62.0% to RMB3.0 million (US$0.4 million) in the second quarter 2008 from RMB1.9 million, representing 4.4% of total net revenues, in the second quarter 2007. This increase was mainly due to expenses associated with our anti-TNF mAb and HPV vaccine programs.

Sales, marketing and distribution expense, representing 44.6% of total net revenues, increased by 31.9% to RMB26.6 million (US$3.9 million) in the second quarter 2008 from RMB20.1 million, representing 46.8% of total net revenues, in the second quarter 2007 as a result of increased personnel, conference, promotional and advertising costs in line with the expansion of our sales force, marketing activities and geographical network in China.

General and administrative expense, representing 15.9% of total net revenues, increased by 186.2% to RMB9.5 million (US$1.4 million) in the second quarter 2008 from RMB3.3 million, representing 7.7% of total net revenues, in the second quarter 2007. This increase was primarily a result of increases in personnel costs and professional fees associated with on-going efforts to imp
'/>"/>

SOURCE 3SBio Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. 3SBio Inc. to Present at the UBS Global Life Sciences Conference
2. 3SBio Inc. to Hold Annual General Meeting
3. 3SBio Inc. Schedules 2007 Third Quarter Earnings Release On Tuesday, November 13, 2007
4. 3SBio Inc. To Present at the 19th Annual Piper Jaffray Health Care Conference
5. 3SBio Inc. Announces Appointment of Kevin Sow Peng Teo as Chief Financial Officer
6. 3SBio Inc. to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
7. 3SBio Inc. Schedules 2007 Fourth Quarter and Full Year Earnings Release on Wednesday, February 20, 2008
8. 3SBio Inc. Announces Change to the Board of Directors
9. 3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2007 Results
10. 3SBio Inc. Announces Promotion of David Chen as Chief Operating Officer
11. 3SBio Inc. Approves Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... (PRWEB) May 06, 2015 Park ... announced NX-Hivac, the only high vacuum AFM system in ... for failure analysis semiconductor manufacturing. Park NX-Hivac is ideal ... failure analysis solutions in highly doped semiconductor processing where ... , The high vacuum scanning spreading resistance microscopy ...
(Date:5/6/2015)... 2015 The Remedy Group , ... for the specialty pharmacy industry, will be exhibiting, presenting, ... Specialty Pharmacy Summit. The Summit will be held May ... and is the largest annual gathering for the specialty ... from pharmacy providers, pharma/biotech manufacturers, and payers, to learn ...
(Date:5/5/2015)... May 5, 2015 Roka Bioscience, Inc. (NASDAQ: ... testing solutions for the detection of foodborne pathogens,  today announced ... Bank of America Merrill Lynch 2015 Health Care Conference on ... at Encore at the Wynn, Las Vegas NV. ... presentation will be available through the investor relations section of ...
(Date:5/5/2015)... 05, 2015 Research and Markets ... addition of the "Separation Systems Market ... Macromolecules which include protein, RNA, ... are broken into smaller molecules, during production ... requires various advanced systems like centrifugation, liquid ...
Breaking Biology Technology:Park Systems Introduces Park NX-Hivac, a High Vacuum SSRM AFM System for Optimal Results in Semiconductor Manufacturing Failure Analysis 2Park Systems Introduces Park NX-Hivac, a High Vacuum SSRM AFM System for Optimal Results in Semiconductor Manufacturing Failure Analysis 3The Remedy Group presenting at the 2015 Armada Specialty Pharmacy Summit: The Pitfalls to Growth and Maintaining the Patient Experience 2Global Separation Systems Market in Biotechnology 2015-2019 - Trends and Forecasts for the $28 Billion Market 2
... CITY, Feb. 12 /PRNewswire-FirstCall/ - AEterna Zentaris Inc.,(NASDAQ: ... company focused on,endocrine therapy and oncology, today reported ... agonist linked to doxorubicin,has commenced in its Phase ... had begun in December 2007. This open-label,non-comparative multi-center ...
... Candidates Featured -, SOUTH SAN FRANCISCO, Calif., ... company focused on the discovery,and development of monoclonal ... been selected for presentation at the meeting,of American ... Diego on,April 12-16, 2008., "We are pleased ...
... 12 Nektar,Therapeutics (Nasdaq: NKTR ) announced ... a drug delivery service provider to a,therapeutics drug ... corporate functions, and strengthen,decision-making and execution within the ... a world-class drug development company,and these changes are ...
Cached Biology Technology:AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers 2AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers 3AEterna Zentaris Reports First Patients Treated with Anti-Cancer Compound AEZS-108 in Phase 2 Trial in Ovarian and Endometrial Cancers 4Raven biotechnologies to Provide Updates on Oncology Pipeline With Four AACR Presentations 2Raven biotechnologies to Provide Updates on Oncology Pipeline With Four AACR Presentations 3Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization 2Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization 3
(Date:4/14/2015)... April 14, 2015  HYPR Corp. today announced ... ® ) Alliance tm , an industry consortium ... commit to share technology and collaborate to deliver ... interoperable, more secure and private, and easier to ... verification that protects sensitive user information and eliminates ...
(Date:4/10/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cjk4gb/security ... Competitive Profiles - NEC" report to their offering. ... will continue to supply a range of IT security ... company focus on the development of a Big Data ... in the Asia-Pacific region is ...
(Date:4/2/2015)... In the current eight ... the strongest competitors, showing outstanding performance in recognition ... is capable of a throughput of 5.000.000 fingerprints ... be ten times faster than most competitors and ...      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ) , ...
Breaking Biology News(10 mins):HYPR Corp. Joins the FIDO Alliance 2HYPR Corp. Joins the FIDO Alliance 3NEC Security Competitive Profile 2015 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3
... A world-class St. Augustine spa called “perfect” by past ... a “perfect 10” business opportunity for entrepreneurs with an eye for beauty and ... Designed by renowned ... is part of the highly-rated Laterra Resort, located in the World Golf Village ...
... April 27 /PRNewswire-FirstCall/ - Aeterna Zentaris Inc. (NASDAQ: ... development company specialized in oncology and endocrinology, announced today that ... notifying it that the closing price per share of the ... bid price for 10 consecutive trading days and that, as ...
... be able to survive the harsh environs of Mars ... according to research published in the April 2010 issue ... The search for life on Mars remains a ... Institutes. To preserve the pristine environments, the bioloads on ...
Cached Biology News:Plastic Surgeons Rate Auction of World-Class Florida Laterra Spa May 21 a 'Perfect 10,' Great Business Opp for Celebrity Retreat 2Plastic Surgeons Rate Auction of World-Class Florida Laterra Spa May 21 a 'Perfect 10,' Great Business Opp for Celebrity Retreat 3Plastic Surgeons Rate Auction of World-Class Florida Laterra Spa May 21 a 'Perfect 10,' Great Business Opp for Celebrity Retreat 4
... Tecans state-of-the-art software for all your biopharmaceutical ... in a single, scalable software package. The ... simplifying the control of all Freedom instruments ... EVO 100 with one liquid handling arm ...
... Kit is an advanced system for isolating DNA from ... be used directly for any downstream application. ... to use in 56 minutes Low melting point ... and TBE gels No specialised equipment required ...
... in hybridization incubators with rotators. Graduated, ... size PP plug-seal screw-cap with O-ring ... three lengths to accept different size ... O-rings available separately. • Comp Dim: ...
... efficient extraction of DNA fragments from 150 bp to ... procedure uses GelMelt solution to dissolve the gel slice, ... membrane in a spin column format. After a wash ... Each spin column can bind up to 20 g ...
Biology Products: